Sundmacher R, Cantell K, Skoda R, Hallermann C, Neumann-Haefelin D
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978 Nov 30;208(4):229-33. doi: 10.1007/BF00419377.
Thirty-eight patients with virologically proven dendritic keratitis were treated using either debridement plus human leukocyte interferon (HLI) or debridement plus human fibroblast interferon (HFI) in a randomized, double-blind study. We administered one drop of HLI or HFI (1 X 10(6) reference units/ml) daily and found no significant difference in the action of either type of interferon.
在一项随机双盲研究中，对38例经病毒学证实的树枝状角膜炎患者采用清创术加人白细胞干扰素（HLI）或清创术加人成纤维细胞干扰素（HFI）进行治疗。我们每天滴注一滴HLI或HFI（1×10⁶参考单位/毫升），发现两种干扰素的作用没有显著差异。
